DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253 | -12.8% | 1,021 | -15.6% | 0.04% | -9.3% |
| Q2 2023 | $290 | -4.9% | 1,210 | 0.0% | 0.04% | -6.5% |
| Q1 2023 | $305 | -23.9% | 1,210 | -19.9% | 0.05% | -25.8% |
| Q4 2022 | $401 | -99.9% | 1,510 | -11.7% | 0.06% | -23.5% |
| Q3 2022 | $442,000 | +1.8% | 1,710 | 0.0% | 0.08% | +8.0% |
| Q2 2022 | $434,000 | -10.5% | 1,710 | +3.4% | 0.08% | +10.3% |
| Q1 2022 | $485,000 | -10.8% | 1,654 | 0.0% | 0.07% | -4.2% |
| Q4 2021 | $544,000 | +7.9% | 1,654 | 0.0% | 0.07% | 0.0% |
| Q3 2021 | $504,000 | +15.6% | 1,654 | +1.7% | 0.07% | +16.4% |
| Q2 2021 | $436,000 | -13.1% | 1,626 | -27.1% | 0.06% | -19.7% |
| Q1 2021 | $502,000 | +1.4% | 2,230 | 0.0% | 0.08% | -1.3% |
| Q4 2020 | $495,000 | +3.1% | 2,230 | 0.0% | 0.08% | -4.9% |
| Q3 2020 | $480,000 | +21.8% | 2,230 | 0.0% | 0.08% | +14.1% |
| Q2 2020 | $394,000 | +70.6% | 2,230 | +33.8% | 0.07% | +36.5% |
| Q1 2020 | $231,000 | -36.4% | 1,667 | -29.5% | 0.05% | -3.7% |
| Q4 2019 | $363,000 | +49.4% | 2,364 | +40.4% | 0.05% | +50.0% |
| Q3 2019 | $243,000 | +1.2% | 1,684 | +0.2% | 0.04% | +5.9% |
| Q2 2019 | $240,000 | +8.6% | 1,680 | +0.2% | 0.03% | 0.0% |
| Q1 2019 | $221,000 | -26.1% | 1,676 | -42.2% | 0.03% | -38.2% |
| Q4 2018 | $299,000 | -14.3% | 2,901 | -9.8% | 0.06% | +10.0% |
| Q3 2018 | $349,000 | +25.1% | 3,216 | +13.8% | 0.05% | +16.3% |
| Q2 2018 | $279,000 | +0.7% | 2,826 | 0.0% | 0.04% | -2.3% |
| Q1 2018 | $277,000 | – | 2,826 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |